Featured Research

from universities, journals, and other organizations

Activating The Lung's Antioxidant Defense By Targeting Nrf2 Inhibits The Development Of Emphysema

Date:
December 22, 2008
Source:
Johns Hopkins University Bloomberg School of Public Health
Summary:
Using a molecule similar to one found in an experimental cancer drug, researchers have demonstrated that activation of a key component of the lung's antioxidant defense system, Nrf2, can prevent emphysema in mice. The researchers believe that activation of Nrf2 could be a novel target for therapies to prevent chronic obstructive pulmonary disease (COPD), which comprises emphysema and chronic bronchitis.

Using a molecule similar to one found in an experimental cancer drug, researchers at the Johns Hopkins Bloomberg School of Public Health demonstrated that activation of a key component of the lung's antioxidant defense system, Nrf2, can prevent emphysema in mice. The researchers believe that activation of Nrf2 could be a novel target for therapies to prevent chronic obstructive pulmonary disease (COPD), which comprises emphysema and chronic bronchitis. COPD is a major public health problem and it is the fourth leading cause of death in the U.S.

"There are no effective therapies for COPD and there is an urgent need to develop novel intervention strategies. Targeting the Nrf2 pathway presents a novel strategy which needs to be tested for their efficacy in intervening COPD in patients," said Shyam Biswal, PhD, senior author of the study and an associate professor in the Bloomberg School of Public Health's Department of Environmental Health Sciences and the Division of Pulmonary and Critical Care Medicine at the Johns Hopkins School of Medicine.

Nrf2 (nuclear factor erythroid-derived 2-related factor 2) works as a "master gene" that turns on numerous antioxidant and pollutant-detoxifying genes to protect the lungs from environmental pollutants, such as cigarette smoke. Biswal previously identified that disruption of Nrf2 expression in mice caused early onset and severe emphysema. More recently, his team demonstrated for the first time a close correlation between the Nrf2 decline and the progression of COPD in humans.

For the current study, Biswal, along with postdoctoral fellows, Thomas Sussan, PhD, Tirumalai Rangasamy, PhD, and David J. Blake, PhD, observed mice exposed to cigarette smoke to determine if activation of Nrf2 could prevent emphysema. Exposed mice—fed a diet containing CDDO-Im, which is known to activate Nrf2—were significantly less likely to have oxidative stress and lung cell damage associated with emphysema. The researchers also noted substantially improved function in the portion of the heart responsible circulating oxygenated blood through the body—a function that is typically diminished with emphysema. CDDO-Im is closely related to CDDO-Me, an experimental cancer drug approved for phase II clinical trials.

"Nrf2 is an important regulator of the body's antioxidant defense system, and activation of Nrf2 is a promising therapeutic strategy for attenuating COPD progression in patients," said Thomas Sussan, PhD, lead author of the study.

According to the researchers, COPD affects more than 16 million Americans and it is the only disease among the top 10 causes of death with a rising mortality rate in the United States. It is predicted to be the third largest cause of death by 2020 and has already reached worldwide epidemic proportions.

Additional authors are Tirumalai Rangasamy, David J. Blake, Deepti Malhotra, Hazim El-Haddad, Djahida Bedja, Melinda S. Yates, Ponvijay Kombairaju, Masayuki Yamamoto, Karen T. Liby, Michael B. Sporn, Kathleen L. Gabrielson, Hunter C. Champion, Rubin M. Tuder and Thomas W. Kensler. The researchers were supported by grants from the National Institutes of Health, National Heart, Lung and Blood Institute, the National Cancer Institute, the Flight Attendants Medical Research Institute, the Maryland Cigarette Restitution Fund, the National Foundation for Cancer Research, Reata Pharmaceuticals, the National Institute on Environmental Health Sciences, PhRMA Foundation and the Bernard A. and Rebecca S. Bernard Foundation.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School of Public Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proceeding of the National Academy of Sciences, Dec 22, 2008

Cite This Page:

Johns Hopkins University Bloomberg School of Public Health. "Activating The Lung's Antioxidant Defense By Targeting Nrf2 Inhibits The Development Of Emphysema." ScienceDaily. ScienceDaily, 22 December 2008. <www.sciencedaily.com/releases/2008/12/081222221533.htm>.
Johns Hopkins University Bloomberg School of Public Health. (2008, December 22). Activating The Lung's Antioxidant Defense By Targeting Nrf2 Inhibits The Development Of Emphysema. ScienceDaily. Retrieved April 24, 2014 from www.sciencedaily.com/releases/2008/12/081222221533.htm
Johns Hopkins University Bloomberg School of Public Health. "Activating The Lung's Antioxidant Defense By Targeting Nrf2 Inhibits The Development Of Emphysema." ScienceDaily. www.sciencedaily.com/releases/2008/12/081222221533.htm (accessed April 24, 2014).

Share This



More Health & Medicine News

Thursday, April 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Fungus Killing Bats, Spreading in US

Deadly Fungus Killing Bats, Spreading in US

AP (Apr. 24, 2014) A disease that has killed more than six million cave-dwelling bats in the United States is on the move and wildlife biologists are worried. White Nose Syndrome, discovered in New York in 2006, has now spread to 25 states. (April 24) Video provided by AP
Powered by NewsLook.com
Companies Ramp Up Wellness to Lower Health Costs

Companies Ramp Up Wellness to Lower Health Costs

AP (Apr. 24, 2014) That little voice telling you to exercise, get in shape and get healthy is probably coming from your boss. More companies are beefing up wellness programs to try and cut down their health care costs. (April 24) Video provided by AP
Powered by NewsLook.com
Blood From World's Oldest Woman Suggests Life Limit

Blood From World's Oldest Woman Suggests Life Limit

Newsy (Apr. 24, 2014) Scientists say for the extremely elderly, their stem cells might reach a state of exhaustion. This could limit one's life span. Video provided by Newsy
Powered by NewsLook.com
FDA Wants To Ban Sales Of E-Cigarettes To Minors

FDA Wants To Ban Sales Of E-Cigarettes To Minors

Newsy (Apr. 24, 2014) The Food and Drug Administration wants to crack down on the use of e-cigarettes, banning the sale of the product to minors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins